Compare NODK & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NODK | OSUR |
|---|---|---|
| Founded | 1946 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.6M | 247.6M |
| IPO Year | 2016 | 2000 |
| Metric | NODK | OSUR |
|---|---|---|
| Price | $15.19 | $3.51 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 21.7K | ★ 439.4K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $285,050,000.00 | $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $25.08 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.37 | $2.08 |
| 52 Week High | $16.70 | $4.58 |
| Indicator | NODK | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 41.82 |
| Support Level | $14.96 | $2.86 |
| Resistance Level | $16.44 | $4.29 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 65.96 | 48.84 |
NI Holdings Inc is a stockholding company. Through its subsidiaries, the company operates in the insurance industry, offering homeowners and farmowners insurance policies, crop insurance policies, home insurance policies, etc. These insurance products are distributed through a network of exclusive and independent agents across the United States. The group's reportable segments are: Private Passenger Auto, Non-Standard Auto, Home and Farm, Crop, and All Other (which mainly consists of commercial, assumed reinsurance, and its excess liability business). Maximum revenue is generated from the Home and Farm segment.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.